单位：[1]Eli Lilly Australia Pty Ltd, Macquarie Pk, NSW, Australia[2]Shanghai 9 Peoples Hosp, Shanghai, Peoples R China[3]W China Hosp, Chengdu, Peoples R China四川大学华西医院[4]Shanghai Sixth Peoples Hosp, Shanghai, Peoples R China[5]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China江苏省人民医院[6]Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[7]Beijing Ji Shui Tan Hosp, Beijing, Peoples R China[8]Second Affiliated Hosp, Wenzhou, Peoples R China[9]Yuying Childrens Hosp Wenzhou Med C, Wenzhou, Peoples R China[10]Nanjing Drum Tower Hosp, Nanjing, Peoples R China[11]Peking Univ, Hosp 1, Beijing 100871, Peoples R China[12]Eli Lilly Australia Pty Ltd, W Ryde, NSW, Australia[13]Eli Lilly Canada, Toronto, ON, Canada[14]Eli Lilly Asia, Shanghai, Peoples R China
第一作者单位：[1]Eli Lilly Australia Pty Ltd, Macquarie Pk, NSW, Australia
推荐引用方式(GB/T 7714)：
Blair J. M.,Dai K. R.,Chen D. C.,et al.Comparison of the effects of teriparatide and calcitonin in the treatment of postmenopausal Chinese women with osteoporosis[J].BONE.2009,44:S74-S74.doi:10.1016/j.bone.2009.01.162.
APA：
Blair, J. M.,Dai, K. R.,Chen, D. C.,Zhang, Z. L.,Zhang, K. Q....&Luo, T. H..(2009).Comparison of the effects of teriparatide and calcitonin in the treatment of postmenopausal Chinese women with osteoporosis.BONE,44,
MLA：
Blair, J. M.,et al."Comparison of the effects of teriparatide and calcitonin in the treatment of postmenopausal Chinese women with osteoporosis".BONE 44.(2009):S74-S74
